government
FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
Summary by The San Antonio Editorial Desk · Based on reporting by Matthew Perrone, Associated Press , KSAT 12 (ABC affiliate)
· July 23, 2026
· 4 min read
Health advisers met Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. In the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 in favor of...
Story provenance No corrections
Summary created by The San Antonio Editorial Desk — automated, rule-governed Original reporting Matthew Perrone, Associated Press, KSAT 12 (ABC affiliate) Original story Read at the source Source published Jul 23, 2026 Indexed here Jul 23, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway In the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 in favor of broadening access to a chemical called BPC-157, one of the most popular peptides among longevity and wellness influencers.
Why this matters in The San Antonio
San Antonio residents who follow wellness trends on social media may have come across testimonials about peptide injections, but the FDA's review of these substances serves as a crucial checkpoint for local health and safety. With the city's thriving wellness community, it's likely that some San Antonio businesses and individuals are already involved in the peptide industry, either as sellers or users. The FDA's meeting highlights the need for rigorous scientific evaluation of these substances, particularly given the lack of clinical evidence supporting their safety and effectiveness. As the FDA considers allowing peptides to be compounded by pharmacies, San Antonio's medical community will be watching closely, given the potential implications for local healthcare and the city's reputation as a hub for health and wellness. The presence of doctors and pharmacists with financial ties to the peptide industry on the advisory panel also raises questions about the potential for conflicts of interest in the city's own medical and wellness communities.
About this story
Original reporting by KSAT 12 (ABC affiliate) . The San Antonio surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KSAT 12 (ABC affiliate) . Have a tip or correction? Contact our newsroom .
Category: government ·
Published: July 23, 2026 ·
Source: KSAT 12 (ABC affiliate) ·
Reading time: 4 min
Frequently asked about this story
What is this story about? Health advisers met Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. In the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 in favor of...
When was this published? This article was first published on July 23, 2026 by KSAT 12 (ABC affiliate) and curated for The San Antonio readers.
Who reported this story? This story was reported by Matthew Perrone, Associated Press at KSAT 12 (ABC affiliate). To learn more about how The San Antonio selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more government coverage from The San Antonio, or browse our daily briefing and topic hubs .
← Back to all news
More government →
Today’s briefing
Subscribe to newsletter